Fevertree Drinks Shares Outstanding History (FEVR)
Fevertree Drinks reported 116.7M shares outstanding at the end of fiscal 2024.
View full Fevertree Drinks company overviewFevertree Drinks annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 116.7M | 51,285 | +0.04% |
| 2023 | 2023-12-31 | 116.7M | 122,972 | +0.11% |
| 2022 | 2022-12-31 | 116.6M | 13,677 | +0.01% |
| 2021 | 2021-12-31 | 116.5M | — | — |
Fevertree Drinks quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | 121.1M | — | — |
| Q4 2024 | 2024-12-31 | 116.7M | — | — |
Fevertree Drinks shares outstanding trends
Between the periods ended 2021-12-31 and 2024-12-31, Fevertree Drinks's shares outstanding moved from 116.5M to 116.7M, a change of 187,934. The latest reported quarter, Q2 2025, shows 121.1M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
reported period-end shares
TickerStat displays period-end common shares from official filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fevertree Drinks source filings ↗Community posts
Fever-Tree’s US partnership supports growth as the UK returns to expansion
Fever-Tree ($FEVR) reported adjusted brand revenue of £183.6 million in the first half, an 8% increase at constant exchange rates. US revenue grew 11% on the same basis as its Molson Coors partnership gained momentum, while the UK returned ...